The lack of effective human studies makes the need for REMFS clinical trials highly significant in advancing this anti-amyloid strategy for future AD treatments.
1
—
—
The lack of effective human studies makes the need for REMFS clinical trials highly significant in advancing this anti-amyloid strategy for future AD treatments.